NCT02170532View on ClinicalTrials.gov

Aerosolized Beta-Agonist Isomers in Asthma

PHASE4CompletedINTERVENTIONAL

Enrollment

10

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions

Asthma

Interventions

DRUG

levalbuterol

0.5 ml. levalbuterol

DRUG

saline

0.5ml saline

OTHER

levalbuterol MDI

DEVICE

breath actuated nebulizer

DEVICE

aerochamber max

DRUG

ipratroprium

Sponsors

Lead Sponsor

Duke University

All Listed Sponsors

lead

Duke University

OTHER

NCT02170532 - Aerosolized Beta-Agonist Isomers in Asthma | Biotech Hunter | Biotech Hunter